ISHIBASHI Kei

写真a

Title

Postdoctoral Researcher

Current Affiliation Organization 【 display / non-display

  • Duty ,  School of Medicine (Clinical Medicin) ,  Department of Urology ,  Postdoctoral Researcher

Graduate School 【 display / non-display

  • Fukushima Medical University ,  Graduate School, Division of Medicine ,  Doctor's Course ,  Completed ,  JAPAN

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Urology

 

Papers 【 display / non-display

  • Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.

    Ishibashi K, Haber T, Breuksch I, Gebhard S, Sugino T, Kubo H, Hata J, Koguchi T, Yabe M, Kataoka M, Ogawa S, Hiraki H, Yanagida T, Haga N, Thüroff JW, Prawitt D, Brenner W, Kojima Y

    Oncotarget ,  2017.07

    Multiple Authorship

    DOI PubMed

  • Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.

    Oguro T$, Ishibashi K$,*, Sugino T, Hashimoto K, Tomita S, Takahashi N, Yanagida T, Haga N, Aikawa K, Suzutani T, Yamaguchi O, Kojima Y $:Equally contributed

    European J Cancer ,  49 (7) 1715 - 1724 ,  2013.05

    Multiple Authorship

  • Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.

    Kumagai S, Ishibashi K, Kataoka M, Oguro T, Kiko Y, Yanagida T, Aikawa K, Kojima Y

    Cancer science ,  107 (11) 1632 - 1641 ,  2016.11

    Multiple Authorship ,  ISBN: 1347-9032

    DOI PubMed

  • Does body habitus of patients affect operative difficulty during retroperitoneal laparoscopic radical nephrectomy?

    Akaihata H, Haga N, Yanagida T, Aikawa K, Ishibashi K, Takahashi N, Ogawa S, Oguro T, Kataoka M, Kojima Y.

    J Endourol ,  27 (2) 208 - 213 ,  2013.02

    Multiple Authorship

  • Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.

    Ishibashi K, Tokumoto T, Tanabe K, Shirakawa H, Hashimoto K, Kushida N, Yanagida T, Inoue N, Yamaguchi O, Toma H, Suzutani T.

    Clin Infect Dis. ,  Jul 1;45 ((1)) 60 - 7 ,  2007.05

    Multiple Authorship

display all >>

Books 【 display / non-display

  • Renal Transplantation

    (Page:119-142)

    その他の出版機関 ,  2012

Presentations 【 display / non-display

  • TYROSINE-KINASE INHIBITORS TREATMENT INDUCES IL-6 SECRETION ON RENAL CARCINOMA CELLS

    AUA 2014 Annual Meeting , 

    2014.05
     
     

  • IL-6 induced by TKI on RCC cells  - as a mechanism of resistance to TKI therapy

    29th EAU Congress , 

    2014.04
     
     

  • The presence of antibodies against the AD2 epitope of cytomegalovirus(CMV) glycopprotein B(gB)is associated with clinical outcomes after renal transplantation in D+-R+transplant recipients.

    AUA annual meeting 2013 , 

    2013.05
     
     

  • IL-6 and SOCS3 regulates cell proliferation in renal cell carcinoma cells

    AUA annual meeting 2013 , 

    2013.05
     
     

  • Combination therapy with humanized antihuman IL-6R antibody and interferon-α successfully prevents the growth of 786-O renal cell carcinoma cells.

    AUA Annual Meeting 2013 , 

    2013.05
     
     

display all >>